Tradestie Institutional Equity Comparison Engine · Market Close Feb 20, 2026

GMRE vs CIO: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

GMRE Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 5–3 Matrix Metrics)

GMRE Overall Winner 6-Pillar Tally: GMRE 4 – 1 CIO (1 Tie) Matrix Metrics: GMRE 5 – 3 CIO

As of Feb 20, 2026, Global Medical REIT Inc. (GMRE) is the stronger overall head-to-head candidate over City Office Reit, Inc. (CIO) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). GMRE carries a Unified Composite Score of 59.3/100 (HOLD) at $35.98 (N/M Forward P/E, 24.5% operating margin), whereas CIO carries 66.2/100 (BUY) at $6.99 (N/M Forward P/E, 19.6% operating margin).

  • Composite vs. Pillar Nuance: While CIO currently prints a higher short-term Unified Composite Score (66.2/100 BUY vs. GMRE 59.3/100 HOLD), GMRE captures the overall institutional head-to-head verdict (5–3 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (24.5% vs. 19.6% operating margin) and revenue trajectory (+8.6% vs. -12.0% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About GMRE vs CIO
GMRE NYSE Head-to-Head Winner
Global Medical REIT Inc.
Real Estate Investment Trusts
$35.98
-0.03% 1D
Market Cap $980.0M
TTM Revenue $145M
Forward P/E N/M
Beta / 30D Vol 2.30β · 20% Vol
Unified Composite Score
59.3 / 100 HOLD
Tech 55.0 Fund 52.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (3.8% over 20 days), RSI 54
RSI-14: 54.0 · SMA20: $35.70 · SMA50: $35.13
CIO NYSE
City Office Reit, Inc.
Real Estate Investment Trusts
$6.99
-0.14% 1D
Market Cap $282.5M
TTM Revenue $164M
Forward P/E N/M
Beta / 30D Vol 0.19β · 2% Vol
Unified Composite Score
66.2 / 100 BUY
Tech 75.0 Fund 65.0 Flow 50.0 Mom 70.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 65
RSI-14: 64.9 · SMA20: $6.97 · SMA50: $6.92

6-Pillar Scorecard Institutional Category Breakdown (GMRE 4 – 1 CIO)

Columns: Metric · GMRE · CIO
1. Valuation Multiples CIO
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 6.8x 1.7x
2. Growth & Scale GMRE
Revenue Growth (YoY) +8.6% -12.0%
Earnings Growth (YoY) +200.0% -52.3%
TTM Revenue (USD) $145M $164M
Market Cap $980.0M $282.5M
3. Profitability & Quality GMRE
Gross Margin 99.9% 60.5%
Operating Margin 24.5% 19.6%
Net Profit Margin 1.7% -74.2%
Return on Equity (ROE) 0.4% -17.8%
4. Balance Sheet & Cash Flow GMRE
Cash Generation (TTM) $88M EBITDA $83M EBITDA
Cash Flow Margin 60.4% EBITDA Mgn 51.0% EBITDA Mgn
Net Cash / Leverage $30.61 Book/Sh · 0.4% ROE $12.34 Book/Sh · -17.8% ROE
Dividend Yield 10.04% 4.29%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 43.6% (86th %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Neutral
6. R&D & Supply-Chain Moat GMRE
OpEx & R&D Intensity 75.4% of Rev ($109M) 40.9% of Rev ($67M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Scale & Operating Efficiency Moat
Supply-Chain Role REIT - Healthcare Facilities Operator REIT - Office Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: GMRE (5) vs CIO (3)
Institutional Metric GMRE CIO Criterion Row Edge
Market Capitalization
Scale
$980.0M $282.5M Larger Scale GMRE
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+8.6% -12.0% Higher Growth GMRE
Operating Margin (TTM)
Profitability
24.5% 19.6% Higher Margin GMRE
Net Profit Margin
Profitability
1.7% -74.2% Higher Margin GMRE
Return on Equity (ROE)
Capital Efficiency
0.4% -17.8% Higher ROE GMRE
52-Week Range Position
Momentum
75% ($6–$46) 99% ($4–$7) Stronger Trend CIO
Beta / 30D Volatility
Risk Regime
2.30β · 20% Vol 0.19β · 2% Vol Lower Realized Risk CIO
Unified Institutional Score
Composite Signal
59.3 / 100 (HOLD) 66.2 / 100 (BUY) Higher Composite CIO
Trailing 12M Revenue (USD)
Operating Scale
$145M $164M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
99.9% 60.5% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 6.8x EV/Rev N/M PEG · 1.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$88M EBITDA ($30.61 Book/Sh · 0.4% ROE) $83M EBITDA ($12.34 Book/Sh · -17.8% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon GMRE +5.57 pp
GMRE: +6.15% · CIO: +0.58%
3M Horizon GMRE +13.01 pp
GMRE: +13.44% · CIO: +0.43%
6M Horizon GMRE +363.37 pp
GMRE: +386.87% · CIO: +23.5%
1Y Horizon CIO +54.23 pp
GMRE: -16.9% · CIO: +37.33%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GMRE vs CIO. Trailing 12-month operating profitability (GMRE 24.5% vs CIO 19.6%) and valuation multiples (GMRE N/M vs CIO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

GMRE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$145M
Gross Margin99.9%
Op. Margin24.5%
ROE / Fwd P/E0.4% · N/M
CIO ADR TTM Benchmark FX-Normalized USD
TTM Revenue$164M
Gross Margin60.5%
Op. Margin19.6%
ROE / Fwd P/E-17.8% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
GMRE UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 43.6%
IV Percentile 86th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GMRE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CIO UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CIO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
GMRE Moat Profile Scale & Operating Efficiency Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $980.0M market capitalization and 24.5% operating margin.
OpEx & R&D Reinvestment 75.4% of Rev ($109M)
90D Engineering Disclosures 0 Published
CIO Moat Profile Scale & Operating Efficiency Moat
REIT - Office Operator
Competes within the REIT - Office value chain with $282.5M market capitalization and 19.6% operating margin.
OpEx & R&D Reinvestment 40.9% of Rev ($67M)
90D Engineering Disclosures 0 Published

Investor FAQ GMRE vs CIO Key Questions & Quantitative Answers

As of Feb 20, 2026, Global Medical REIT Inc. (GMRE) is the stronger overall head-to-head candidate over City Office Reit, Inc. (CIO) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). GMRE carries a Unified Composite Score of 59.3/100 (HOLD) at $35.98 (N/M Forward P/E, 24.5% operating margin), whereas CIO carries 66.2/100 (BUY) at $6.99 (N/M Forward P/E, 19.6% operating margin). Composite vs. Pillar Nuance: While CIO currently prints a higher short-term Unified Composite Score (66.2/100 BUY vs. GMRE 59.3/100 HOLD), GMRE captures the overall institutional head-to-head verdict (5–3 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (24.5% vs. 19.6% operating margin) and revenue trajectory (+8.6% vs. -12.0% YoY).

GMRE leads the Growth & Scale pillar: GMRE posts +8.6% YoY revenue growth and +200.0% YoY earnings growth on $145M TTM revenue (99.9% gross margin, 24.5% operating margin), compared with CIO at -12.0% YoY revenue growth and -52.3% YoY earnings growth on $164M TTM revenue (60.5% gross margin, 19.6% operating margin). On trailing 12-month operating scale, GMRE generates $145M in USD-normalized revenue versus $164M for CIO. In operating R&D and SG&A reinvestment, GMRE deploys 75.4% of Rev ($109M) (0 90-day corporate R&D disclosures) versus 40.9% of Rev ($67M) (0 disclosures) for CIO.

CIO screens cheaper on headline valuation multiples. GMRE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 6.8x EV/Revenue (60.4% EBITDA margin), whereas CIO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 1.7x EV/Revenue (51.0% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GMRE (0.4% ROE) versus CIO (-17.8% ROE) capital efficiency.

In options market volatility and institutional positioning, GMRE carries 43.6% implied volatility (86th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.30β · 20% Vol realized risk). By comparison, CIO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.19β · 2% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Feb 20, 2026. For educational research only; not investment advice.